Pune, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The Global Pacemakers Market is expected to clock US$ ~6.06 billion by 2031 owing to the rising prevalence of cardiovascular diseases and technological advancements in pacemaker devices.
Request sample PDF of this report at: https://growthplusreports.com/product/pacemaker-market
Growth Factor
Various government and private organizations across the globe are providing the necessary fundings and grants in order to encourage R&D in pacemakers. For instance, in November 2019, Texas Heart Institute (THI) was awarded a prestigious four-year, US$ 2.39 million grant from the National Institutes of Health (NIH) to support the further development of a novel pacemaker system that is both leadless and wirelessly powered.
The global pacemakers market has been analyzed from four different perspectives–Implantability, Technology, End User, and Region.
Excerpts from ‘By Implantability Segmentation’
The global pacemakers market has been segmented majorly into two distinct categories depending on implantability, viz. implantable pacemaker and external pacemaker. The implantable pacemaker segment dominated the market with largest share in 2020. The growth of the segment can mainly be attributed to greater usage of this type of device by the growing geriatric population suffering from various cardiovascular diseases. The chance of pacemaker implantation increases dramatically with age. Over 70% of all pacemakers are implanted in patients over the age of 65.
Excerpts from ‘By Region Segmentation’
The global pacemakers market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share in the global pacemakers market in 2020, followed by Asia Pacific, Europe, and Rest of the World (RoW). The large share of North American market can be attributed to well developed healthcare infrastructure, growing prevalence of cardiovascular diseases, and ease of access to different types of devices due to greater presence of prominent players in the region.
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global pacemakers market are
- Medtronic
- Boston Scientific Corporation
- Biotronik
- Abbott
- Lepu Medical Technology (Beijing) Co., Ltd
- Pacetronix
- Osypka Medical
- Medico S.p.A.
- Oscor Inc
- MicroPort® CRM
Report Scope:
Report Coverage | Details |
Forecast Period | 2021 to 2031 |
Forecast Period 2021 to 2031 CAGR | 2.5% |
2031 Market Value | USD 6.06 billion |
Base Year | 2020 |
Historical Data | 2018 and 2019 |
Number of pages | 100 - 120 |
Segment Covered | Implantability, Technology, Single-Chamber Pacemaker, and Biventricular, End-User |
Table of Content:
- INTRODUCTION
- Market Ecosystem
- Geographic Scope
- Timeline Under Consideration
- Historical Years – 2018 & 2019
- Base Year – 2020
- Forecasted Years – 2021 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom-Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trend (COVID-19 Perspective)
- Technological Advancements
- Key Players & Their Competitive Positioning (2020)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL PACEMAKER MARKET - ANALYSIS & FORECAST, BY IMPLANTABILITY
- Implantable Pacemaker
- External Pacemaker
- GLOBAL PACEMAKER MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
- Dual-Chamber Pacemaker
- Single-Chamber Pacemaker
- Biventricular/CRT Pacemaker
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Speak to an analyst to know Covid-19 impact on this industry: https://growthplusreports.com/product/pacemaker-market
About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary and primary research, market modelling and forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.